entocort enema 2,3 mg rect. susp. (tabl.)
tillotts pharma gmbh - budesonide, micronised 2,3 mg/ml - tablet for rectal suspension - 2,3 mg - budesonide 2.3 mg - budesonide
entocort rectal 2.3 mg, tablets and liquid for the preparation of a rectal suspension
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - rectal suspension - budesonide 2.3 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents
entocort enema 0.02mg/ml dispersible tablet and solution for rectal suspension
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - budesonide - dispersible tablet, rectal suspension - budesonide 0.02 milligram(s)/millilitre - antidiarrheals, intestinal antiinflammatory/antiinfective agents
entocort enema 0.02mg/ml dispersible tablet and solution for rectal suspension
tillotts pharma uk ltd wellingore hall, wellingore lincolnshire, ln5 0hx, united kingdom - budesonide - dispersible tablet rectal suspension - budesonide 0.2 mg/ml - antidiarrheals, intestinal antiinflammatory/antiinfective agents
entocort 2mg/100ml enema
tillotts pharma uk ltd - budesonide - enema - 20microgram/1ml
entocort
chiesi new zealand limited t/a emerge health - budesonide 3mg - modified release capsule - 3 mg - active: budesonide 3mg excipient: acetyl tributyl citrate ethylcellulose gelatin methacrylic acid - ethyl acrylate copolymer polysorbate 80 purified talc simeticone sugar spheres triethyl citrate - entocort capsules are indicated for the induction of remission in patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.
entocort enema
tillotts pharma gmbh - budesonide - enema - 2.3mg - budesonide 2.3mg - anti-inflammatory agents
entocort budesonide 3mg modified release capsule bottle
chiesi australia pty ltd - budesonide, quantity: 3 mg - capsule, modified release - excipient ingredients: sodium lauryl sulfate; iron oxide yellow; tributyl acetylcitrate; colloidal anhydrous silica; titanium dioxide; liquid paraffin; dimeticone 1000; purified talc; iron oxide black; ethylcellulose; gelatin; triethyl citrate; methacrylic acid copolymer; iron oxide red; polysorbate 80; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide; maize starch; sucrose - the induction of remission in adult patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.
entocort
astrazeneca pty ltd - budesonide -
entocort
astrazeneca limited - budesonide 2.25mg; ; - modified release capsule - 2.25 mg - active: budesonide 2.25mg excipient: acetyl tributyl citrate ethylcellulose gelatin methacrylic acid copolymer polysorbate 80 purified talc simeticone sugar spheres triethyl citrate